COVID-19 and SARS-CoV-2: Years After Emergence
In this week’s MDPI Special Issue on Novel COVID-19 Molecular Therapeutics, researchers outline three experimental drug candidates—SARS-CoV-2 protease inhibitors, lipid nanoparticle-encapsulated mRNA vaccines targeting Omicron subvariants, and a monoclonal antibody ... Read More